Targeting ELK-1 transcription factor and mechanosensitive MDM4 receptor using an HCN channel blocker alleviates lung fibrosis

Pulmonary Pharmacology & Therapeutics 2026

View at publisher
Authors: Sahar A Helmy, Nesma A. Abd Elrazik
DOI: 10.1016/j.pupt.2026.102408
Cited by: 0
References: 70

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary Hypertension Research and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Pulmonary Pharmacology & Therapeutics
Volume
92
Pages
102408–102408
Publication date
19 January 2026
Language
EN